Published in Steroids on January 26, 1989
Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice. PLoS Genet (2014) 0.78
From Endocrinology to Intracrinology. Endocr Pathol (1998) 0.78
Aromatase in human common epithelial ovarian neoplasms. Am J Pathol (1996) 0.76
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol (1998) 5.74
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90
Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst (2001) 3.88
Sexual differentiation of the central nervous system. Science (1981) 2.95
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet (2008) 2.79
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74
[Toxic hepatitis caused by droxicam]. Med Clin (Barc) (1992) 2.69
The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health (1995) 2.43
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene (2008) 2.31
Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J (2001) 2.24
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (2001) 2.12
A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci U S A (1990) 2.11
Overexpression of metallothionein confers resistance to anticancer drugs. Science (1988) 2.03
Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol (1995) 2.02
Mitotic silencing of human rRNA synthesis: inactivation of the promoter selectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation. EMBO J (1998) 2.01
Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther (1988) 2.01
Risk factors for rapid-onset cervical cancer. Am J Obstet Gynecol (1999) 1.91
Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res (1981) 1.91
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2005) 1.85
Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol (1990) 1.82
An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol (1981) 1.80
Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J Exp Med (1988) 1.78
Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res (1997) 1.75
Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA (1999) 1.73
Postsplenectomy sepsis and mortality in adults. JAMA (1982) 1.70
The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res (1975) 1.69
Small bowel motility in diabetics. Am J Dig Dis (1969) 1.64
Psychosocial benefits of a cancer support group. Cancer (1986) 1.62
Advanced squamous cell carcinoma of the cervix with recent normal Papanicolaou tests. Lancet (1980) 1.61
Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem (1980) 1.61
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med (1987) 1.60
Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr (2000) 1.60
High mobility group 1 protein is not stably associated with the chromosomes of somatic cells. J Cell Biol (1997) 1.60
Pulsatile patterns of gonadotropin release in subjects with and without ovarian function. J Clin Endocrinol Metab (1972) 1.59
Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol (2000) 1.59
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest (1976) 1.58
Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res (1995) 1.57
Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med (1997) 1.55
Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol (1998) 1.54
Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer (1983) 1.53
Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res (1992) 1.52
The RNA polymerase I-specific transcription initiation factor UBF is associated with transcriptionally active and inactive ribosomal genes. Chromosoma (1993) 1.51
Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause (1999) 1.50
A case-control study of cancer of the endometrium. Am J Epidemiol (1982) 1.50
Malignant lymphomas involving the ovary. A clinicopathologic analysis of 39 cases. Am J Surg Pathol (1993) 1.48
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Papillary endothelial hyperplasia in the thyroid following fine-needle aspiration. Arch Pathol Lab Med (1991) 1.46
Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol (1994) 1.45
Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol (1999) 1.45
Novel embryonic genes are preferentially expressed by autonomously replicating rat embryonic and neointimal smooth muscle cells. Circ Res (2000) 1.45
Identical genetic changes in different histologic components of Wilms' tumors. J Natl Cancer Inst (1997) 1.44
Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr (1993) 1.43
Signet ring carcinoma of the female breast: a clinicopathologic analysis of 24 cases. Cancer (1981) 1.42
Fetal neural graft survival. Lancet (1990) 1.40
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther (1987) 1.39
Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology. Cancer (1999) 1.39
Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res (1991) 1.38
Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci U S A (1995) 1.37
Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma. Hum Pathol (1999) 1.37
Effect of purified luteinizing hormone releasing factor on normal and hypogonadotrophic anosmic men. Nature (1971) 1.36
Hormonal regulation of K+-channel messenger RNA in rat myometrium during oestrus cycle and in pregnancy. Nature (1987) 1.35
Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst (1997) 1.35
Scintigraphic findings and follow up in Erdheim-Chester disease. Eur J Nucl Med (1990) 1.33
Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol (1993) 1.33
Collagen changes in the human uterine cervix at parturition. Am J Obstet Gynecol (1978) 1.30
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology (1972) 1.29
Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci U S A (1983) 1.29
Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett (1999) 1.28
Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol (1986) 1.26
Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol (1992) 1.25
Transforming growth factor beta levels in rat wound chambers. J Surg Res (1987) 1.25
Adenoid cystic carcinoma of the breast. Data from the Connecticut Tumor Registry and a review of the literature. Ann Surg (1987) 1.23
Treatment of ovarian stromal tumors. Am J Obstet Gynecol (1976) 1.22
Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology (1997) 1.21
The estimation of pituitary luteinizing hormone secretion. J Clin Endocrinol Metab (1973) 1.21
A hypothesis concerning the general basis of organogenetic congenital anomalies. Am J Obstet Gynecol (1987) 1.21
Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol (2000) 1.21
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. Br J Cancer (2009) 1.20
Estrogen induction of a small, putative K+ channel mRNA in rat uterus. Neuron (1990) 1.20
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev (1999) 1.19
Overlapping functions of the pRb family in the regulation of rRNA synthesis. Mol Cell Biol (2001) 1.18
Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry (2001) 1.18
Peripheral plasma oestradiol and luteinizing hormone concentrations during the oestrous cycle of the rat. J Endocrinol (1970) 1.18
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest (2000) 1.18
Genetic analysis of synchronous mucinous tumors of the ovary and appendix. Hum Pathol (1996) 1.17
Collecting duct carcinoma of the kidney. Hum Pathol (1990) 1.17
Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology (1978) 1.17
Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol (1999) 1.16
Adenocarcinoid (mucinous carcinoid) of the appendix. Gastroenterology (1984) 1.15
Langerhans cell histiocytosis of the female genital tract. Cancer (1991) 1.13
Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol (2000) 1.12
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene (2011) 1.12
Allelic loss in ovarian cancer. Int J Cancer (1993) 1.12
Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol (1986) 1.11